OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Microbiology Reviews is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Extracutaneous sporotrichosis	352
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections	197
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility	175
Transmission of Infections during Cardiopulmonary Resuscitation	155
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	125
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance	120
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease	109
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”	107
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus	106
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves	102
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	100
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities	99
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases	94
Viral infections and pathogenesis of glaucoma: a comprehensive review	88
Progression of antibiotic resistance in Neisseria meningitidis	83
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options	78
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics	75
Evolutionary Pathways and Trajectories in Antibiotic Resistance	74
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance	70
Review of BCG immunotherapy for bladder cancer	69
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms	65
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control	65
A review of post-exposure strategies for high-consequence viral pathogens in the laboratory	65
Neisseria gonorrhoeae vaccines: a contemporary overview	61
Drug-resistant Acinetobacter baumannii : mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen	60

Congenital Syphilis: a Review of Global Epidemiology	58
Bacterial and fungal infections in persons who inject drugs	57
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature	57
Diagnosis, Management, and Future Control of Cholera	56
BCG therapy in bladder cancer and its tumor microenvironment interactions	55
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease	55
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections	54
Aspergillus terreus Species Complex	52
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	52
Rapid and accurate testing for urinary tract infection: new clothes for the emperor	49
Trained Immunity as a Preventive Measure for Surgical Site Infections	49
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome	48
Harnessing the host response for precision infectious disease diagnosis	46
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)	45
Artemisinin-resistant malaria	45
Agnostic Sequencing for Detection of Viral Pathogens	44
Editorial Board	43
2021 Acknowledgment of CMR Reviewers	43